Related references
Note: Only part of the references are listed.Single-Dose Indigenous Liposomal Amphotericin B in the Treatment of Indian Visceral Leishmaniasis. A Phase 2 Study
Shyam Sundar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome (R) for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial
Eltahir A. G. Khalil et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination
Kebede Deribe et al.
PARASITES & VECTORS (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
Koert Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2011)
Leishmaniasis chemotherapy-challenges and opportunities
S. L. Croft et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India
Prabhat K. Sinha et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
Asrat Hailu et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients
P Minodier et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2003)
A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study
CP Thakur
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Share Paper
